The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -48.62% this year. Over the last six months, there has been a stronger performance of -30.85%. The price of SXTC fallen by 17.23% during the last 30 days period. For the last 5-days stocks have improved 17.91%.
China SXT Pharmaceuticals Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $9.38 on 08/21/23, and the lowest price during that time was $1.10, recorded on 04/15/24.
52-week price history of SXTC Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. China SXT Pharmaceuticals Inc’s current trading price is -78.24% away from its 52-week high, while its distance from the 52-week low is 85.44%. The stock’s price range over this timeframe has been between $1.10 and $9.38. The shares of the Healthcare sector company recorded a trading volume of approximately 22.73 million for the day, which was comparatively higher than the average daily volume of 0.62 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
China SXT Pharmaceuticals Inc (SXTC) has experienced a quarterly rise of 10.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.16M and boasts a workforce of 78 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9561, with a change in price of +0.8200. Similarly, China SXT Pharmaceuticals Inc recorded 946,194 in trading volume during the last 100 days, posting a change of +42.27%.
SXTC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SXTC stands at 0.62. Similarly, the long-term debt-to-equity ratio is also 0.06.
SXTC Stock Stochastic Average
The raw stochastic average for China SXT Pharmaceuticals Inc over the last 50 days is presently at 73.13%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 73.13%. Further, the company’s Stochastic %K and %D values for the last 20 days were 27.41% and 14.96%, respectively.
